Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan T van Oosterom

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|April 20, 2002
Gene-expression profiling to classify soft-tissue sarcomasLuc Y Dirix, Allan T van Oosterom
Clinical Pharmacokinetics|November 11, 2003
Pharmacology of anticancer drugs in the elderly populationHans Wildiers, Martin S Highley, Ernst A de Bruijn, et al.
Sarcoma|June 4, 2008
A sarcoma at the site of previous extravasation of adriamycinJoris Ceulemans, Ivo De Wever, Raf Sciot, et al.
Anti-Cancer Drugs|December 13, 2006
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancerHerlinde Dumez, Helen Gall, Renaud Capdeville, et al.
Critical Reviews in Clinical Laboratory Sciences|October 19, 2002
Oxidative DNA damage: biological significance and methods of analysisGunther Guetens, Gert De Boeck, Martin Highley, et al.
Anti-Cancer Drugs|March 20, 2002
Altered irinotecan metabolism in a patient receiving phenytoinRon H J Mathijssen, Alex Sparreboom, Herlinde Dumez, et al.
Expert Opinion on Pharmacotherapy|June 4, 2008
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcomaPatrick Schöffski, Herlinde Dumez, Pascal Wolter, et al.
Anti-Cancer Drugs|April 2, 2004
Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II studyRandal D'hondt, Robert Paridaens, Hans Wildiers, et al.
American Journal of Clinical Oncology|August 26, 2009
Phase II study of plitidepsin 3-hour infusion every 2 weeks in patients with unresectable advanced medullary thyroid carcinomaEric Baudin, Jean P Droz, Luis Paz-Ares, et al.
Pharmacological Reviews|December 17, 2004
Vascular endothelial growth factor and angiogenesisAnn Hoeben, Bart Landuyt, Martin S Highley, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|April 20, 2002
Gene-expression profiling to classify soft-tissue sarcomasLuc Y Dirix, Allan T van Oosterom
Clinical Pharmacokinetics|November 11, 2003
Pharmacology of anticancer drugs in the elderly populationHans Wildiers, Martin S Highley, Ernst A de Bruijn, et al.
Sarcoma|June 4, 2008
A sarcoma at the site of previous extravasation of adriamycinJoris Ceulemans, Ivo De Wever, Raf Sciot, et al.
Anti-Cancer Drugs|December 13, 2006
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancerHerlinde Dumez, Helen Gall, Renaud Capdeville, et al.
Critical Reviews in Clinical Laboratory Sciences|October 19, 2002
Oxidative DNA damage: biological significance and methods of analysisGunther Guetens, Gert De Boeck, Martin Highley, et al.
Anti-Cancer Drugs|March 20, 2002
Altered irinotecan metabolism in a patient receiving phenytoinRon H J Mathijssen, Alex Sparreboom, Herlinde Dumez, et al.
Expert Opinion on Pharmacotherapy|June 4, 2008
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcomaPatrick Schöffski, Herlinde Dumez, Pascal Wolter, et al.
Anti-Cancer Drugs|April 2, 2004
Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II studyRandal D'hondt, Robert Paridaens, Hans Wildiers, et al.
American Journal of Clinical Oncology|August 26, 2009
Phase II study of plitidepsin 3-hour infusion every 2 weeks in patients with unresectable advanced medullary thyroid carcinomaEric Baudin, Jean P Droz, Luis Paz-Ares, et al.
Pharmacological Reviews|December 17, 2004
Vascular endothelial growth factor and angiogenesisAnn Hoeben, Bart Landuyt, Martin S Highley, et al.
Pageof 4